Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease?, Alzheimer's & Dementia, vol.5, issue.4, pp.348-360, 2009. ,
DOI : 10.1016/j.jalz.2008.12.001
APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle, Neuroscience Letters, vol.483, issue.2, pp.96-100, 2010. ,
DOI : 10.1016/j.neulet.2010.07.066
Alzheimer's disease plaques and tangles: Cemeteries of a Pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction, Neurochemistry International, vol.58, issue.3, pp.301-320, 2011. ,
DOI : 10.1016/j.neuint.2010.12.003
Antiviral agents in Alzheimer's disease: hope for the future?, Therapeutic Advances in Neurological Disorders, vol.3, issue.3, pp.141-152, 2010. ,
DOI : 10.1177/1756285610370069
Seropositivity to Herpes Simplex Virus Antibodies and Risk of Alzheimer's Disease: A Population-Based Cohort Study, PLoS ONE, vol.25, issue.11, p.3637, 2008. ,
DOI : 10.1371/journal.pone.0003637.t003
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease, Nature Reviews Neurology, vol.359, issue.3, pp.131-144, 2010. ,
DOI : 10.1038/nrneurol.2010.4
Association of plasma amyloid ?? with risk of dementia: The prospective Three-City Study, Neurology, vol.73, issue.11, pp.847-853, 2009. ,
DOI : 10.1212/WNL.0b013e3181b78448
Metaanalysis of plasma amyloid-beta levels in Alzheimer's disease, J Alzheimers Dis, vol.26, pp.365-375, 2011. ,
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease, Nature Genetics, vol.12, issue.10, pp.1094-1099, 2009. ,
DOI : 10.1038/ng.439
Herpes simplex virus type 1, apolipoprotein E, and cholesterol: A dangerous liaison in Alzheimer???s disease and other disorders, Progress in Lipid Research, vol.45, issue.1, pp.73-90, 2006. ,
DOI : 10.1016/j.plipres.2005.11.003
Herpes Simplex Virus Type 1 in Alzheimer's Disease: The Enemy Within, Journal of Alzheimer's Disease, vol.13, issue.4, pp.393-405, 2008. ,
DOI : 10.3233/JAD-2008-13405
Alzheimer's disease, The Lancet, vol.368, issue.9533, pp.387-403, 2006. ,
DOI : 10.1016/S0140-6736(06)69113-7
URL : https://hal.archives-ouvertes.fr/hal-01098836
Plasma {beta}-Amyloid and Cognitive Decline, Arch Neurol, vol.67, pp.1485-1490, 2010. ,
Plasma A?? and PET PiB binding are inversely related in mild cognitive impairment, Neurology, vol.77, issue.2, pp.125-131, 2011. ,
DOI : 10.1212/WNL.0b013e318224afb7
Peripheral A?? subspecies as risk biomarkers of Alzheimer's disease, Proceedings of the National Academy of Sciences, vol.105, issue.37, pp.14052-14057, 2008. ,
DOI : 10.1073/pnas.0805902105
Association of Plasma ??-Amyloid Level and Cognitive Reserve With Subsequent Cognitive Decline, JAMA, vol.305, issue.3, pp.261-266, 2011. ,
DOI : 10.1001/jama.2010.1995
Herpes simplex virus interferes with amyloid precursor protein processing, BMC Microbiology, vol.5, issue.1, p.48, 2005. ,
DOI : 10.1186/1471-2180-5-48
Herpes Simplex Virus Dances with Amyloid Precursor Protein while Exiting the Cell, PLoS ONE, vol.17, issue.Pt 6, p.17966, 2011. ,
DOI : 10.1371/journal.pone.0017966.s015
Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques, The Journal of Pathology, vol.27, issue.12, pp.131-138, 2009. ,
DOI : 10.1002/path.2449
Herpes simplex virus infection causes cellular ??-amyloid accumulation and secretase upregulation, Neuroscience Letters, vol.429, issue.2-3, pp.95-100, 2007. ,
DOI : 10.1016/j.neulet.2007.09.077
HSV-1 promotes Ca(2+)-mediated APP phosphorylation and Abeta accumulation in rat cortical neurons, Neurobiol Aging, 2010. ,
Herpes simplex virus type I induces the accumulation of intracellular beta-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells, Neurobiol Aging, 2011. ,
APP Processing Induced by Herpes Simplex Virus Type 1 (HSV-1) Yields Several APP Fragments in Human and Rat Neuronal Cells, PLoS ONE, vol.122, issue.Suppl 2, p.13989, 2010. ,
DOI : 10.1371/journal.pone.0013989.s004
Antivirals Reduce the Formation of Key Alzheimer's Disease Molecules in Cell Cultures Acutely Infected with Herpes Simplex Virus Type 1, PLoS ONE, vol.63, issue.301, p.25152, 2011. ,
DOI : 10.1371/journal.pone.0025152.t002
Stimulation of Enveloped Virus Infection by ??-Amyloid Fibrils, Journal of Biological Chemistry, vol.277, issue.38, pp.35019-35024, 2002. ,
DOI : 10.1074/jbc.M203518200
The Alzheimer's Disease-Associated Amyloid ??-Protein Is an Antimicrobial Peptide, PLoS ONE, vol.5, issue.3, p.9505, 2010. ,
DOI : 10.1371/journal.pone.0009505.s002
Inflammation and Anti-Inflammatory Strategies for Alzheimer???s Disease ??? A Mini-Review, Gerontology, vol.56, issue.1, pp.3-14, 2010. ,
DOI : 10.1159/000237873
Oxidative stress hypothesis in Alzheimer???s disease: a reappraisal, Trends in Pharmacological Sciences, vol.29, issue.12, pp.609-615, 2008. ,
DOI : 10.1016/j.tips.2008.09.001
Role of oxidative damage in the pathogenesis of viral infections of the nervous system, Histol Histopathol, vol.20, pp.957-967, 2005. ,
Autophagy, amyloidogenesis and Alzheimer disease, Journal of Cell Science, vol.120, issue.23, pp.4081-4091, 2007. ,
DOI : 10.1242/jcs.019265
Implication of the Immune System in Alzheimer's Disease: Evidence from Genome-Wide Pathway Analysis, Journal of Alzheimer's Disease, vol.20, issue.4, pp.1107-1118, 2010. ,
DOI : 10.3233/JAD-2010-100018
Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease, Proceedings of the National Academy of Sciences, vol.107, issue.32, pp.14164-14169, 2010. ,
DOI : 10.1073/pnas.1009485107
Autophagy in Alzheimer???s disease, Expert Review of Neurotherapeutics, vol.10, issue.7, pp.1209-1218, 2010. ,
DOI : 10.1586/ern.10.84
Herpes simplex virus type 1 in brain and risk of Alzheimer's disease, The Lancet, vol.349, issue.9047, pp.241-244, 1997. ,
DOI : 10.1016/S0140-6736(96)10149-5
Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review, Lipids in Health and Disease, vol.9, issue.1, p.8, 2010. ,
DOI : 10.1186/1476-511X-9-8
Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease?, Alzheimer's & Dementia, vol.6, issue.1, pp.83-84, 2010. ,
DOI : 10.1016/j.jalz.2009.07.136
Plasma biomarkers for mild cognitive impairment and Alzheimer's disease, Brain Research Reviews, vol.61, issue.2, pp.69-80, 2009. ,
DOI : 10.1016/j.brainresrev.2009.05.003
The influence of matrix type, diurnal rhythm and sample collection and processing on the measurement of plasma ??-amyloid isoforms using the INNO-BIA plasma A?? forms multiplex assay, The Journal of Nutrition, Health and Aging, vol.16, issue.105, pp.220-225, 2009. ,
DOI : 10.1007/s12603-009-0062-5
Factors affecting A?? plasma levels and their utility as biomarkers in ADNI, Acta Neuropathologica, vol.305, issue.3, pp.401-413, 2011. ,
DOI : 10.1007/s00401-011-0861-8
Seroprevalence of HSV-1 and HSV-2 infection in the general French population, Sexually Transmitted Infections, vol.78, issue.3, pp.201-203, 2002. ,
DOI : 10.1136/sti.78.3.201
Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population, Neuroepidemiology, vol.22, pp.316-325, 2003. ,
Novel Approach for Specific Detection of Herpes Simplex Virus Type 1 and 2 Antibodies and Immunoglobulin G and M Antibodies, Clinical and Vaccine Immunology, vol.7, issue.6, pp.904-908, 2000. ,
DOI : 10.1128/CDLI.7.6.904-908.2000
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: The Three-City Study, Neurology, vol.64, issue.9, pp.1531-1538, 2005. ,
DOI : 10.1212/01.WNL.0000160114.42643.31
URL : https://hal.archives-ouvertes.fr/inserm-00175952